RCE recce pharmaceuticals ltd

Recce Pharmaceuticals (ASX:RCE) to dual list on FSE

  1. 7,925 Posts.
    lightbulb Created with Sketch. 1230
    • Recce Pharmaceuticals (RCE) has begun the process to dual list on the Frankfurt Stock Exchange (FSE)
    • The company has appointed Deutsche Gesellschaft Für Wertpapieranalyse (DGWA) as its investor and corporate relations advisor in Europe
    • DGWA will engage prospective investors and drive awareness of Recce's productsDual listing on the FSE will give Recce exposure to multiple retail and institutional investors in the European Union
    • The company will keep the market updated as the listing progresses Shares in Recce are steady on the market and are trading at $1.05 per share

    Read the full article on The Market Herald here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $83.62M
Open High Low Value Volume
29.0¢ 30.0¢ 28.5¢ $37.25K 127.7K

Buyers (Bids)

No. Vol. Price($)
4 161128 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 9666 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.